SCHEMBL181032

SCHEMBL181032

CCCCCCCC(C)CCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.58
OPRM1 P35372 1/20 0.50
LMNA P02545 2/20 0.48
TSHR P16473 2/20 0.47
THRB P10828 1/20 0.47
SPHK1 Q9NYA1 1/20 0.46
DNM1 Q05193 2/20 0.46
PRKD3 O94806 1/20 0.44
PRKCG P05129 1/20 0.44
PRKCB P05771 1/20 0.44
PRKCA P17252 1/20 0.44
PRKCH P24723 1/20 0.44
PRKCI P41743 1/20 0.44
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44
PRKCZ Q05513 1/20 0.44
PRKCD Q05655 1/20 0.44
PRKD1 Q15139 1/20 0.44
ADH1B P00325 1/20 0.43
ADH1C P00326 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31509242 1.00 ACE2 (0.58) ACE2OPRM1LMNATSHRTHRB
SCHEMBL652603 1.00 ACE2 (0.58) ACE2OPRM1LMNATSHRTHRB
SCHEMBL3407397 1.00 ACE2 (0.58) ACE2OPRM1LMNATSHRTHRB
SCHEMBL3469393 1.00 ACE2 (0.58) ACE2OPRM1LMNATSHRTHRB
SCHEMBL450698 1.00 ACE2 (0.58) ACE2OPRM1LMNATSHRTHRB
SCHEMBL14484285 1.00 ACE2 (0.58) ACE2OPRM1LMNATSHRTHRB
SCHEMBL19058823 1.00 ACE2 (0.58) ACE2OPRM1LMNATSHRTHRB
SCHEMBL650705 1.00 ACE2 (0.58) ACE2OPRM1LMNATSHRTHRB
SCHEMBL872663 1.00 ACE2 (0.58) ACE2OPRM1LMNATSHRTHRB
SCHEMBL31509410 1.00 ACE2 (0.58) ACE2OPRM1LMNATSHRTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 868 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250290891-A1 SYSTEMS AND METHODS FOR POINT-OF-CARE ELECTROCHEMICAL DETECTION OF BIOMARKERS IN LIQUIDS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2025-09-18 US claimed
CN-120058495-A Process for the preparation of mixed alkyl ketones and alkyl alcohols 武汉希音新材料科技有限公司 2025-05-30 CN claimed
US-20250052738-A1 BIOMARKER UNIVERSITY OF LEICESTER (GB) 2025-02-13 US claimed
CN-119060557-A Preparation method of gamma-quinacridone organic pigment with high hiding power 绍兴上虞新利化工有限公司 2024-12-03 CN claimed
CN-118993844-A Process for the preparation of mixed alkyl ketones and alkyl alcohols 武汉希音新材料科技有限公司 2024-11-22 CN claimed
EP-4373395-A2 BIOMARKER University of Leicester (GB) 2024-05-29 EP claimed
US-20240140888-A1 COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER BIOSYNTHIS (FR) 2024-05-02 US claimed
US-11925455-B2 Methods for diagnosing malaria WASHINGTON UNIVERSITY (US) 2024-03-12 US claimed
EP-4321651-A1 COMPOSITION COMPRISING AN ALKANE AND AN OXO ESTER Biosynthis (FR) 2024-02-14 EP claimed
WO-2023002167-A2 BIOMARKER UNIVERSITY OF LEICESTER (GB) 2023-01-26 WO claimed
CN-108034512-A A kind of Multi-function dry washing material and preparation method thereof 东莞智高化学科技有限公司 2018-05-15 CN claimed
US-9568821-B2 Patterning process SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-02-14 US claimed
US-9507262-B2 Resist top-coat composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-11-29 US claimed
CN-105518053-A Aliphatic polycarbonate compositions and methods NOVOMER INC 2016-04-20 CN claimed
US-20160068638-A1 ALIPHATIC POLYCARBONATE COMPOSITIONS AND METHODS NOVOMER, INC. 2016-03-10 US claimed
EP-2992031-A2 ALIPHATIC POLYCARBONATE COMPOSITIONS AND METHODS Novomer, Inc. (US) 2016-03-09 EP claimed
US-20150234278-A1 PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-08-20 US claimed
US-20150234274-A1 RESIST TOP-COAT COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-08-20 US claimed
WO-2014178972-A2 ALIPHATIC POLYCARBONATE COMPOSITIONS AND METHODS NOVOMER, INC. (US) 2014-11-06 WO claimed
EP-1000070-B1 SILICON-CONTAINING CHAIN EXTENDERS AORTECH BIOMATERIALS PTY LTD (AU) 2003-09-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240140888-A1 COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER ALKBH2, ABHD12, FAAH2 ACE2 596/4885OPRM1 855/4885LMNA 876/4885
US-11925455-B2 Methods for diagnosing malaria AQP4, CCL11, MAL2 ACE2 496/4885OPRM1 2439/4885LMNA 3425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.